Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis” - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Response to the Editor Concerning the “Indirect Comparison of Long-Term Efficacy Maintenance between Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

  • By

  • Kim Rand

  • Kurt Gebauer

  • Yousef Binamer

  • Yung-Tsu Cho

  • Manny Papadimitropoulos

  • Chao Yang

  • Helena Agell

  • Bülent Akmaz

  • Lucia Seminario-Vidal

  • June 26, 2026

Share

Original Source(s)

Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

  • by Kim Rand, Kurt Gebauer, Yousef Binamer, Yung-Tsu Cho, Manny Papadimitropoulos, Chao Yang, Helena Agell, Bülent Akmaz, Lucia Seminario-Vidal

  • June 26, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Correction: Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report

Extracellular vesicles in atopic dermatitis: unraveling pathogenic mediators and engineering therapeutic vectors